hamburger-icon
close-icon

invest-iconInvest

trade-iconTrade

depository-iconTrading Platforms

depository-iconDepository

watch-iconWatch Markets

depository-iconFPI

watch-iconMerchant Banking

watch-iconInstitutional Broking

watch-iconStock Market Institute – AIFE

watch-iconMTF

partner-iconBecome a Partner

partner-iconKnowledge Center

watch-iconResearch

about-iconAbout Us

support-iconSupport

support-iconPricing

support-iconQuick Links

support-iconBlog

hamburger-icon
close-icon

Amanta Healthcare Ltd

  • BSE Code : 544502
  • NSE Symbol : AMANTA
  • ISIN : INE084K01015
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN
Trade Now

up-arrow 136.36 -3.68(-2.63%)

Open Price (₹)

144.99

Prev. Close (₹)

140.04

Volume (No’s)

171,178

Market Cap (₹)

529.48

Low Price (₹)

135.50

High Price (₹)

144.99

 

Book Closure

From Date To Date Announcement
26-Sep-2025 NA Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/09/2025 inter alia to consider and approve Board Meeting Intimation for inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2025 and would also consider the redemption of Preference Shares.
09-Sep-2025 NA Sub: Listing of Equity Shares of Amanta Healthcare Limited (IPO) In pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the list of securities further admitted to dealings on the National Stock Exchange (Capital Market segment) with effect from September 09, 2025 and the designated security codes thereof shall be as specified in Annexure. In pursuance of Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the respective lot sizes in respect of securities above shall be as specified in Annexure. For the purpose of trading on the system, the security shall be identified only by its designated codes and trading in such securities shall be in such lot sizes as specified in Annexure. Members are requested to note that the above security will be part of pre-open session for IPO and Other category of scrips as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012. This circular shall be effective from September 09, 2025. For and on behalf of National Stock Exchange of India Limited Aarti Parmar Manager Symbol AMANTA Name of the Company Amanta Healthcare Limited Series BE* ISIN INE084K01015 Face Value Rs. 10/- Paid-up Value Rs. 10/- Issue Price for the current public issue Rs. 126/- Security Description Equity shares of Rs. 10/- each fully paid up No. of securities 38829351 Distinctive number range As per Annexure I Market lot 1 Pari Passu Yes Lock in details As per Annexure I *Note: Currently the securities shall be available for trading in Series 'BE' and subsequently be shifted to Series 'EQ' as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 Address of Registered and Corporate Office of the Company: Amanta Healthcare Limited 8th Floor, Shaligram Corporates, C.J. Marg, Ambli, Ahmedabad - 380058, Gujarat. Contact Number: 079 67777600 Website: www.amanta.co.in Email id: cs@amanta.co.in Company Secretary and Compliance Officer Ms. Nikhita Dinodia Website: www.amanta.co.in Email id: cs@amanta.co.in Financial Year: April 2025-March 2026 Address of Registrar: MUFG Intime India Private Limited (formerly Link intime India Private Limited) C-101, 1st Floor, 247 Park, L.B.S. Marg Vikhroli (West), Mumbai - 400083, Maharashtra Website: www.linkintime.co.in Email id: amantahealthcare.ipo@linkintime.co.in Tel: (+91) 8108114949 Contact Person: Ms. Shanti Gopalkrishnan
09-Sep-2025 NA Trading Members of the Exchange are hereby informed that effective from Tuesday, September 9, 2025, the equity shares of Amanta Healthcare Limited shall be listed and admitted to dealings on the Exchange in the list of 'T ' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days. Name of the company Amanta Healthcare Limited Registered Office: 8th Floor, Shaligram Corporates,C.J. Marg, Ambli, Ahmedabad - 380058, Gujarat, India Tel: 079 67777600 Email: cs@amanta.co.in Website: www.amanta.co.in No. of Securities 38829351 Equity Shares of Rs.10/- each fully paid up Distinctive Number range 1 To 4617113, 5617114 To 8085513, 8635514 To 13440513, 13532828 To 25607525, 28449886 To 30374764, 34049765 To 34983078, 45230573 To 57236519 Scrip ID on BOLT System AMANTA Abbreviated Name on BOLT System AMANTA Scrip Code 544502 ISIN No. INE084K01015 Market Lot 1 Issue Price for the current Public issue Rs. 126/- per share (Face Value of Rs. 10/- and premium of Rs. 116/-) Date of Allotment in the public issue: September 4, 2025 Pari Pasu Yes Financial Year Mar-31 Lock in detail As per Annexure I Shareholding Pattern As per Annexure II a)Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. b) Further the trading members may please note that the above-mentioned scrip will be a part of Special Pre-open Session (SPOS) on Tuesday, September 9, 2025. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips. c) The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository's records. d) The Registrar to the issue as mentioned in the prospectus is given below MUFG Intime India Private Limited (formerly Link intime India Private Limited) C-101, 1st Floor, 247 Park, L.B.S. Marg Vikhroli (West), Mumbai 400 083, Maharashtra Telephone: +91 8108114949 E-mail: amantahealthcare.ipo@linkintime.co.in Investor grievance e-mail: amantahealthcare.ipo@linkintime.co.in Website: www.linkintime.co.in Contact person: Shanti Gopalkrishnan
NA NA Sub: Trade for Trade - Amanta Healthcare Limited (IPO) Further to Exchange Circular no. NSE/CML/70061 dated September 05, 2025 and pursuant to SEBI guidelines vide circular reference no. CIR/MRD/DP/02/2012 dated January 20, 2012 following securities shall be transferred from trade for trade segment (series: BE) to rolling segment (Series: EQ) with effect from September 23, 2025. Symbol AMANTA Name of the Company Amanta Healthcare Limited For and on behalf of National Stock Exchange of India Limited
NA NA In continuation to the Exchange's notice no. 20250905-31dated Friday, September 5, 2025, Trading Members are hereby informed that the trading in the equity shares of Amanta Healthcare Limited (Scrip Code: 544502) shall be transferred from Trade for Trade segment i.e. (T Group) to Rolling segment with effect from Tuesday, September 23, 2025. Accordingly, the dealings in the equity shares of the company will be shifted under B Group.

NIFTY:24,611.10  Up arrow
-23.80(-0.10%)
SENSEX:80,364.94  Up arrow
-97.32(-0.12%)

Product

Trading


Useful links

Who we are

Connect with us

Stay on top of the markets with our bite-sized newsletter delivered right to your Inbox!

footer-arrow-icon
appstore appstore

#1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Arihant Capital Markets Limited is a SEBI registered stock broker and depository participant. SEBI Registration number: INZ000180939, Member of NSE:07839; BSE :313; NSDL - IN-DP-127-2015 DP ID-IN301983; CDSL DP ID-43000; NCDEX - 01274; MCX - 56565; AMFI - ARN 15114; AMFI-registered Mutual Fund Distributor; ARN registration year - 2004; ARN validity up to- 18/12/2028; SEBI Merchant Banking Reg. No. - MB INM000011070; SEBI Research Analyst Reg. No. - INH000002764 (BSE RA Enlistment No. 5168) . Registered Address: 601, Atlantis Tower, Plot No. 13 A, Scheme N0. 78, Indore 452010 (MP). Corporate office address: #1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Please carefully read the risk disclosure document as prescribed by SEBI, as well as the 'Do’s and Don’ts' provided by NSE, BSE, NCDEX, and MCX. If you have any complaints related to securities broking, kindly contact us at complaint@arihantcapital.com. For DP-related matters, please reach out to us at depository@arihantcapital.com.

If you want to register your complaints through SEBI Score 2.0 Portal please click here. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Investments in securities market are subject to market risks; read all the related documents carefully before investing.

Disclaimer: Arihant Capital Markets Limited is engaged in client based and proprietary trading on various exchanges.

  • ATTENTION INVESTORS :
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • For Stock Broking Transaction 'Prevent unauthorised transactions in your account - update your mobile numbers/email IDs with your stockbrokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.
  • For Depository Transaction 'Prevent Unauthorized Transactions in your demat account - Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day.
  • If you are subscribing to an IPO, there is no need to issue cheques. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
  • Pay 20% or "var + elm" whichever is higher as upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

  • Risk disclosures on Derivatives:
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

  • Advisory - Investors :
  • Ensure that pay-out of funds/securities is received in your account within 1 working day from the date of pay-out.
  • Register for online applications viz Speed-e and Easiest provided by Depositories for online delivery of securities as an alternative to DDPI/POA.
  • Ensure that you receive Contract Notes within 24 hours of your trades and Statement of Account at least once in a quarter from your Stock Broker.
  • If you have opted for running account, please ensure that the stock broker settles your account regularly and in any case not later than 90 days (or 30 days if you have opted for 30 days settlement).
  • Do not keep funds idle with the Stock Broker.
  • Regularly login into your account to verify balances and verify the demat statement received from depositories for correctness.
  • Check messages sent by Exchanges on a monthly basis regarding funds and securities balances reported by the trading member and immediately raise a concern if you notice a discrepancy.
  • Always keep your contact details viz Mobile number / Email ID updated with the stock broker. You may take up the matter with Stock Broker / Exchange if you are not receiving the messages from Exchange / Depositories regularly.
  • If you observe any discrepancies in your account or settlements, immediately take up the same with your stock broker and if the Stock Broker does not respond, with the Exchange/Depositories.
  • Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.
  • Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.

  • As per advisory issued by exchanges, while dealing in options, clients/investors shall avoid the following:
  • Sharing of trading credentials – login id & passwords including OTP’s.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through WhatsApp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Trading in “Options” based on recommendations from unauthorized / unregistered investment advisors and influencers.

Awareness regarding guidelines of margin collection:
1)Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
2)Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
3)Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Issued in the interest of investors

Dear Investor - As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor. https://www.bseipf.com/investors_education.html

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew